New Key Statistics Module, Z-Score and F-Score
NAS:MEDS Key Ratios
| Market Cap $ M | 12.37 |
| Enterprise Value $ M | 5.37 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.84 |
| Price/Sales | 3.97 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 1.28 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 4.00 |
| EPS (TTM) $ | -3.80 |
| Beneish M-Score | 3.24 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.28 |
| EV-to-EBITDA | -0.30 |
| PEG | -- |
| Shares Outstanding M | 1.75 |
| Net Margin (%) | 94.18 |
| Operating Margin % | -316.78 |
| Pre-tax Margin (%) | -454.96 |
| Quick Ratio | 4.18 |
| Current Ratio | 4.18 |
| ROA % (ttm) | 30.00 |
| ROE % (ttm) | 57.59 |
| ROIC % (ttm) | -109.85 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.17 |
MEDS Number of Guru Trades
MEDS Volume of Guru Trades
Gurus Latest Trades with NAS:MEDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MEDS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Trxade Health Inc Insider Transactions
No Available Data
News about NAS:MEDS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers